Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ)
CNY 5.49
(0.37%)
CNY 5.49
(0.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.17 Billion | 2.7 Billion | 2.48 Billion | 2.47 Billion | 2.94 Billion | 2.71 Billion |
| Cost of Revenue | 1.98 Billion | 1.98 Billion | 1.55 Billion | 1.34 Billion | 1.46 Billion | 1.51 Billion |
| Gross Profit | 189.17 Million | 720.27 Million | 925.43 Million | 1.12 Billion | 1.47 Billion | 1.2 Billion |
| Operating Expenses | 653.41 Million | 570.01 Million | 770.63 Million | 658.37 Million | 568.06 Million | 524.76 Million |
| Selling, General and Administrative Expenses | 130.58 Million | 126.01 Million | 125.39 Million | 134.17 Million | 146.15 Million | 117.46 Million |
| Research and Development Expenses | 115.56 Million | 148.49 Million | 167.77 Million | 134.72 Million | 124.48 Million | 113.07 Million |
| Other Expenses | 203 Million | 295.5 Million | 477.46 Million | 389.47 Million | 297.41 Million | -8.54 Million |
| Cost and Expenses | 2.63 Billion | 2.55 Billion | 2.33 Billion | 2 Billion | 2.03 Billion | 2.03 Billion |
| Operating Income | -464.24 Million | 240.38 Million | 122.04 Million | 395.26 Million | 918.82 Million | 710.85 Million |
| Interest Expense | 39.61 Million | 36.54 Million | 21.88 Million | 11.36 Million | 15.5 Million | 42.59 Million |
| Income Tax Expense | -44.64 Million | 14.72 Million | 29.16 Million | 73.8 Million | 141.67 Million | 92.29 Million |
| Earnings before Tax | -466.22 Million | 100.8 Million | 123.03 Million | 393.5 Million | 912.45 Million | 697.29 Million |
| Net Income | -420.05 Million | 88.01 Million | 95.22 Million | 319.71 Million | 770.78 Million | 605 Million |
| Earnings Per Share Basic | -0.26 | 0.05 | 0.06 | 0.20 | 0.48 | 0.38 |
| Earnings Per Share Diluted | -0.26 | 0.05 | 0.06 | 0.20 | 0.48 | 0.38 |
| Weighted Average Shares Outstanding | 1.61 Billion | 1.61 Billion | 1.61 Billion | 1.61 Billion | 1.6 Billion | 1.59 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.61 Billion | 1.61 Billion | 1.61 Billion | 1.61 Billion | 1.6 Billion | 1.59 Billion |
| Gross Margin | 0.09 | 0.27 | 0.37 | 0.45 | 0.50 | 0.44 |
| EBIT Margin | -0.02 | 0.21 | 0.18 | 0.27 | 0.39 | 0.35 |
| Profit Margin | -0.19 | 0.03 | 0.04 | 0.13 | 0.26 | 0.22 |
| EBITDA | -43.99 Million | 508.56 Million | 447.84 Million | 682.56 Million | 1.07 Billion | 939.3 Million |
| Earnings Before Tax Margin | -0.21 | 0.09 | 0.05 | 0.16 | 0.31 | 0.26 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 405.63 Million | 510.37 Million | 528.46 Million | 2.17 Billion | 495.25 Million | 480.18 Million |
| Cost of Revenue | 303.03 Million | 384.55 Million | 362.05 Million | 1.86 Billion | 515.28 Million | 397.77 Million |
| Gross Profit | 102.6 Million | 125.82 Million | 166.4 Million | 304.64 Million | -20.02 Million | 82.41 Million |
| Operating Expenses | 111.69 Million | 126.06 Million | 98.11 Million | 471 Million | 122.47 Million | 121.25 Million |
| Selling, General and Administrative Expenses | 189.71 Million | -18.17 Million | 67.96 Million | - | -117.58 Million | 200.15 Million |
| Research and Development Expenses | 32.73 Million | 34.95 Million | 30 Million | - | 22.28 Million | 29.18 Million |
| Other Expenses | -110.76 Million | -6.28 Million | 820.34 Thousand | -34 Million | -32.63 Million | 63.66 Million |
| Cost and Expenses | 414.73 Million | 510.62 Million | 460.17 Million | 2.33 Billion | 637.75 Million | 519.02 Million |
| Operating Income | -33.49 Million | 6.19 Million | 29 Million | -464.24 Million | -419.88 Million | -62.25 Million |
| Interest Expense | 4.26 Million | 7.53 Million | 11.17 Million | 37.76 Million | 10.8 Million | 9.13 Million |
| Income Tax Expense | -6.92 Million | 2.05 Million | -2.26 Million | -44.64 Million | -38.39 Million | -4.85 Million |
| Earnings before Tax | -33.41 Million | 6.67 Million | 29.82 Million | -466.22 Million | -420.49 Million | -62.77 Million |
| Net Income | -26.12 Million | 5.5 Million | 32.59 Million | -420.05 Million | -381.46 Million | -57.75 Million |
| Earnings Per Share Basic | -0.02 | 0.00 | 0.02 | - | -0.29 | -0.04 |
| Earnings Per Share Diluted | -0.02 | 0.00 | 0.02 | - | -0.29 | -0.04 |
| Weighted Average Shares Outstanding | 1.58 Billion | 1.61 Billion | 1.62 Billion | 1.61 Billion | 1.31 Billion | 1.61 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.58 Billion | 1.61 Billion | 1.62 Billion | 1.61 Billion | 1.31 Billion | 1.61 Billion |
| Gross Margin | 0.25 | 0.25 | 0.31 | 0.14 | -0.04 | 0.17 |
| EBIT Margin | -0.07 | 0.02 | 0.17 | - | -0.28 | -0.03 |
| Profit Margin | -0.06 | 0.01 | 0.06 | -0.19 | -0.77 | -0.12 |
| EBITDA | -29.14 Million | 12.41 Million | 88.01 Million | - | -138.03 Million | -16.54 Million |
| Earnings Before Tax Margin | -0.08 | 0.01 | 0.05 | -0.21 | -0.85 | -0.13 |
GLE
THRL
GRPLTD
THYROCARE
SAKHTISUG
INS